Wednesday, 31 March 2021

Medical Holography Market 2021 Remarking Enormous Growth With Recent Trends & Demand

 The global medical holography market size is expected to reach USD 4.22 billion by 2027 according to a new study by Polaris Market Research. The report “Medical Holography Market Share, Size, Trends, Industry Analysis Report, By Product (Holographic Displays (Laser, Touchable, Piston, Semi-Transparent), Microscope, Print, Software, and Others); By Application (Imaging (Ophthalmology, Dentistry, Urology, Otology, Orthopedics, Others), Medical Education, and Biomedical Research); By End Use (Academic Centers, Pharmaceutical & Biotechnology Companies, Hospitals & Clinics, and Research Laboratories); By Regions; Segment Forecast, 2020 – 2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.

 

Medical holography refers to a technique that can develop three-dimensional images of the targeted organ of the body. Development of 3-D image of any specific organ of interest for the surgeons or physicians is of notable importance as it simplifies the treatment procedure for the physicians.

 

The traditional CT-scan and MRI-scan only delivers 2-D image while requiring the surgeons or physicians to develop a 3-D image in their mind in order to clearly understand the existing situation and thereby, suggest further course of action. Whereas, holography simplifies the same through 3-D imaging technique for healthcare employees.

 

Download Sample Copy @ https://www.polarismarketresearch.com/industry-analysis/medical-holography-market/request-for-sample

 

Medical holography has transformed the healthcare industry with 3-D images of complex organs simplifying the healthcare education & training and boosting the sector research. Various products used in medical holography including holoscopes, software, prints, microscopes, and displays enable the healthcare professionals to view human anatomy in three dimensions.

  

The prominent factors favoring the global market growth include advancement in medical holography technique, investments in development of holography-based gadgets, and extensive adoption of medical holography technique among the healthcare institutions such as hospitals and clinical research organizations (CROs) to assist the physician in their operating procedure and clinical researchers all through their healthcare research.

 

Medical holographic projections and imaging has led to a notable change in training and education as well as all through the biomedical research. Also, digital holograms and holography technique are also extensively deployed all through the hospital training and teaching programs. The 3-dimensional visualization through using the technique develop an interactive and interesting learning environment as holography assists in retaining more information as compared to the traditional learning methodologies.

 

With the rising focus on implementing structural biology across the healthcare institutions and medical training centers, key players operating in the market are proactively focusing on development of holography software and holographic prints to be deployed for training and teaching applications.

 

Get Special Discount On this Research Report @ https://www.polarismarketresearch.com/industry-analysis/medical-holography-market/request-for-discount-pricing

 

The market players are involved in developing cost-effective three-dimensional kit for healthcare professionals and medical students that would assist them while performing dissections and surgeries without any requirement of real organs and bodies. In September 2019, EchoPixel launched an advanced intraoperative software for offering touchless, naked-eye interactive three-dimensional anatomical imaging in order to assist surgeons while performing structural heart surgeries in the operating rooms, laboratories, and hybrid operating rooms. Such technique paves the way for personalizing and improving the delivery of the most demanded minimally invasive procedures.

 

Some of the players involved in the market space include Lyncee Tec, zSpace, Inc., Phase Holographic Imaging AB, RealView Imaging Ltd., Nanolive SA, and Zebra Imaging, EON Reality, Inc., EchoPixel, Holoxica Ltd., Mach7 Technologies, and Ovizio Imaging Systems.

 

Players in the market are focusing on new product development and acquisitions to boost their product portfolio as well as expand their geographical presence across various countries and regions. Moreover, the companies have raised funding to boost the development of the holographic products that contributes to their market share. In July 2020, RealView Imaging raised approximately USD 10 million for the development of a three-dimensional in-Air hologram device.

 

Read More : https://www.prnewswire.com/news-releases/medical-holography-market-size-worth-4-22-billion-by-2027--cagr-28-6-polaris-market-research-301189219.html

CRISPR & Cas Genes Market 2021 Remarking Enormous Growth With Recent Trends & Demand

 The global CRISPR & Cas Genes market size is expected to reach USD 4.75 billion by 2027 according to a new study by Polaris Market Research. The report “CRISPR & Cas Genes Market Size, Share & Trends Analysis Report, By Product & Service (Product {Kits & Enzymes, Libraries, Design Tool, Antibodies, and Others}, and Service {Cell Line Engineering, gRNA Design, Microbial Gene Editing, and DNA synthesis); By Application (Biomedical and Agricultural), and By End Use (Biotechnology & Pharmaceutical Companies, Academics & Government Research Institutes, and Contract Research Organizations (CROs)), and Segment Forecasts, 2020 – 2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.

 

CRISPR refers to a gene editing tool through which the biological researchers and scientists can modify the genomes of various living creatures. The CRISPR technique relies on the antiviral defense mechanism of the bacteria-based CRISPR-Cas9 system. The synthetically created guide RNA is being complexed with Cas9 nuclease and delivered into the cell. Through this technique, the genome of cells can be sliced at any desired location while enabling the removal of available genes or/and adding novel genes in vivo.

 

Download Sample Copy: https://www.polarismarketresearch.com/industry-analysis/crispr-associated-cas-genes-market/request-for-sample

 

The Cas9 nuclease acts as a genetic scissor and used to open both the strands of specific DNA sequence for introducing the desired modification through the deployment of any one of the two techniques. These techniques include knock-in mutations which is enabled through the Homology Directed Repair (HDR) and via Non-Homologous End Joining (NHEJ).

  

The prominent factors favoring the CRISPR & CRISPR-Associated (Cas) genes market growth include technological advancement in gene editing platform and launch of various anti-CRISPR proteins that are expected to improve the overall accuracy of CRISPR technique. SpCas9-HF and eSpCas9 are two novel versions of Cas9 protein that have been designed in laboratory for minimizing the editing activity which is off the target without any use of sgRNAs.

 

According to the American Association for the Advancement of Science (AAAS) February 2020 release, the researchers have integrated two techniques viz. T cell therapy, which exploits the sentry of the body’s immune system for destroying tumors and CRISPR, which is used for editing of DNA. The researchers have found the advanced CRISPR gene editing tool to be very safe when used on three patients suffering from cancer.

 

Do you have questions or special requirements? Ask our industry experts : https://www.polarismarketresearch.com/industry-analysis/crispr-associated-cas-genes-market/speak-to-analyst

 

According to the Stat News February 2019 publication, China’s Science Ministry along with two other government institutions in the country are expected to have funded a study referred to as “CRISPR babies”. This study has resulted in the birth of two genetically altered twin girls in November 2018 in China. Therefore, the biological researchers have successfully achieved a key technique to start pregnancy among humans through the deployment of CRISPR Cas9 gene editing tool on human embryos.

 

Companies such as Addgene, AstraZeneca, Caribou Biosciences, Inc., Cellectis, Cibus, CRISPR Therapeutics, Danaher Corporation, Editas Medicine, Inc., Egenesis, F. Hoffmann-La Roche Ltd., Genscrip, Horizon Discovery Group Plc, Lonza, Mammoth Biosciences, Merck KGaA, New England BioLabs, Synthego, and Takara Bio, Inc. are some of the key players operating in the clustered regularly interspaced short palindromic repeats (CRISPR) & CRISPR-associated (Cas) genes market.

 

Players in the market are focusing on adopting CRISPR & Cas gene editing technology for engineering the blood stem cells and immune cells as a key tool being deployed for enabling drug discovery while creating highly targeted anticancer drugs. Additionally, in May 2020, the U.S. Food and Drug Administration (FDA) has approved the CRISPR-based diagnostic kit for testing of the SARS-CoV-2 COVID-19 coronavirus in laboratory. According to the Nature Journal May 2020 publication, the U.S. has already increased the COVID-19 testing while averaging about 250,000 COVID-19 test per day. The rapid FDA approval to the test kits is expected to boost testing, reducing backlogs.

 

Polaris Market Research has segmented the CRISPR & Cas Genes market report on the basis of product & service, application, end-use, and region

 

Read More : https://www.medgadget.com/2021/01/crispr-cas-genes-market-size-usd-4-75-billion-by-2027-at-a-cagr-of-16-7-polaris-market-research.html

 

https://www.prnewswire.com/news-releases/crispr--cas-genes-market-size-worth-4-75-billion-by-2027--cagr-16-7--polaris-market-research-301193996.html

Vaccine Storage & Packaging Market Future Demands, Latest Innovation By Regional Forecast 2027

 Vaccines are being stored in its original packaging with lids enclosed in separate containers until it is ready for administration to protect it from the light and to provide additional thermal protection. Vaccine storage equipment is the laboratory equipment utilized to maintain and preserve the life of vaccines in the desired condition. It also helps to prevent vaccines from degradation. The global vaccine storage & packaging market size is expected to reach USD 43.8 billion by 2027 according to a new study by Polaris Market Research.

 

Vaccine storage equipment provides storage at varying temperatures ranging from 86 to 65 degree Celsius. Also, it is available in various capacities as per the necessities of an end-user. Moreover, vaccine storage equipment has a huge application in medical laboratories, biotechnology companies, pharmacy stores, blood banks, hospitals & other health care institutes. 

 

Request for a sample copy at:  https://www.polarismarketresearch.com/industry-analysis/vaccine-storage-packaging-market/request-for-sample

 

Recent developments in the market include the launch of Solar Vaccine Refrigerator (SDD refrigerators) and Radio Frequency Identification (RFID) Refrigerators. The advanced refrigerators & freezers help in temperature regulation along with the preservation of vaccines.

 

The growing government venture on vaccination programs will offer lucrative opportunities for the growth of the global market.  The issues including in-house storage and packaging abilities and budget barriers faced by biopharmaceutical organizations, government centers, and academic institutions are estimated to drive the development of the global market. However, technological developments in refrigerators and freezers utilized for vaccine storage and transportation will further fuel the market growth.

 

Market participants such as Lineage Logistics, DB Schenker, AmerisourceBergen, DHL, Thermo Fischer Scientific, Cardinal Logistics, McKesson; Panasonic Healthcare co., LTD., Arctiko A/S, American Biotech Supply, NIPRO are some of the key players operating in the global market.

 

To get Incredible Discounts on this Premium Report, Click At :   https://www.polarismarketresearch.com/industry-analysis/vaccine-storage-packaging-market/request-for-discount-pricing

 

Players in the market are focusing on the mergers & acquisitions, collaborations, product extension & geographical expansion. Also, the companies are making huge investments in research and development activities to develop new products & to compete with the other players.

 

In June 2020, Moderna, Inc., a clinical stage biotechnology company has announced a partnership for the large-scale, manufacturing of the Moderna’s mRNA-based COVID-19 vaccine (mRNA-1273) at Catalent’s biologics research center in Bloomington, Indiana. As per the agreement, Catalent will offer a vial filling & packaging capacity, alongwith the staff requirements for the 24×7 manufacturing operations at the site to assists in development of an initial 100 million doses of the vaccine to supply at the U.S. market by Q3 of 2020.

 

Have Questions? Or make an Inquiry before buying this report Speak to Our Industry Expert: https://www.polarismarketresearch.com/industry-analysis/vaccine-storage-packaging-market/speak-to-analyst

 

Polaris Market Research has segmented the Vaccine Storage & Packaging market report based on function type, end use, and region

Vaccine Storage & Packaging Function Type Outlook (Revenue – USD Million, 2016 – 2027)

  • Storage
    • Storage equipment
      • Refrigerator
      • Freezer
      • Others
    • Service
      • Warehouse storage
      • Transportation
  • Packaging
    • By Packaging Material
      • Vaccine bags, vials, ampoules
      • Corrugated boxes
      • Others
    • By Packaging Level
      • Primary
      • Secondary
      • Tertiary

Vaccine Storage & Packaging End User Outlook (Revenue – USD Million, 2016 – 2027)

  • Retailers
  • Forwarding & Clearing Agents
  • Distributors
  • Others

Read More : https://www.prnewswire.com/news-releases/vaccine-storage--packaging-market-size-worth-43-8-billion-by-2027--cagr-10-4-polaris-market-research-301187108.html

Disaster Recovery as a Service Market Future Demands, Latest Innovation By Regional Forecast 2027

 The global disaster recovery as a service (DRaas) market size is expected to reach USD 23.3 billion by 2027 according to a new study by Polaris Market Research. The report “Global Disaster Recovery as a Service (DRaaS) Market Share, Size, Trends, Industry Analysis Report, By Solution (Backup & Recovery, Real-time Replication, Data Protection, Professional); By Service Provider; By Deployment Model (Public, Private, Hybrid Cloud); By Vertical; By Regions; Segment Forecast, 2020 – 2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.

 

The growing need for greater flexibility, the faster recovery process, and cost-effectiveness are the key factors responsible for market growth. Moreover, the high adoption of hybrid cloud DRaas, and higher penetration in mobile network providers. The demand for DRaaS market solutions is increasing rapidly as enterprises are moving toward cloud-based disaster recovery module. This market incorporates solutions that are required to manage disaster recovery on the cloud.

 

Get Sample Copy : https://www.polarismarketresearch.com/industry-analysis/disaster-recover-service-market/request-for-sample

 

The market is fragmented based on solution, service provider, deployment type, vertical, and region. In terms of solution, the market is segmented into backup and recovery, real-time replication, data protection, and professional. Based on service provider, the disaster as a service market is further bifurcated into cloud providers, managed providers, telecom and communication providers, and others. Based on deployment type, the DRaaS market is further bifurcated into public, private, and hybrid cloud. Based on vertical, the disaster as a service market is further bifurcated into BFSI, consumer goods & retail, government & public sector, healthcare & life sciences, manufacturing, media & entertainment, telecommunication & ITES, and others.

  

Segment Highlight

  • The players including International Business Machines (IBM) Corporation, Microsoft Corporation, and Rackspace Hosting, Inc. together held a significant market share in 2019 owing to their dominance in the DRaaS market
  • North America region is dominating the global disaster as a service market, holding almost one third of the market share throughout the forecast period. The presence of key players and the dynamic business environment, and increasing adoption by small- and large-scale enterprises to enhance productivity and data safety
  • The back-up recovery segment is estimated to hold a major share in the global disaster as a service market, as the majority of the organizations are well aware of cybersecurity and crucial data theft. The back-up market held a significant share in 2019. Real time application market is expected to expand at highest CAGR during the forecast period
  • Based on provider, the managed service providers segment is projected to constitute almost half of the market in 2027. Managed providers are responsible for managing and monitoring IT systems on behalf of their clients.

Have Any Query Or Specific Requirement? Feel Free To Ask Our Industry Experts At : https://www.polarismarketresearch.com/industry-analysis/disaster-recover-service-market/speak-to-analyst

 

List of Key Players

  • Amazon Web Services (AWS)
  • VMware, Inc.
  • International Business Machines (IBM) Corporation
  • Microsoft Corporation
  • Rackspace Hosting, Inc.
  • Verizon Terremark
  • iland Internet Solutions Corporation
  • NTT Communications Corporation
  • Hewlett-Packard (HP)
  • SunGard Availability Services
  • Others

 

Polaris Market Research has segmented the Disaster Recovery as a Service (DRaas) Market report on the basis of solution, service provider, deployment type, vertical, and region

Disaster Recovery as a Service (DRaaS), Solution Outlook (Revenue – USD Million, 2016 – 2027)

  • Backup & Recovery
  • Real-time Replication
  • Data Protection
  • Professional Services
  • Training
  • Education, and Consulting
  • Support and Maintenance

Disaster Recovery as a Service (DRaaS), Service Provider Outlook (Revenue – USD Million, 2016 – 2027)

  • Cloud Service Providers
  • Managed Service Providers
  • Telecom and Communication Service Providers
  • Others

Disaster Recovery as a Service (DRaaS), Deployment Type Outlook (Revenue – USD Million, 2016 – 2027)

  • Public
  • Private
  • Hybrid Cloud

Disaster Recovery as a Service (DRaaS), Vertical Outlook (Revenue – USD Million, 2016 – 2027)

  • BFSI
  • Consumer Goods & Retail
  • Government & Public Sector
  • Healthcare & Life Sciences
  • Manufacturing
  • Media & Entertainment
  • Telecommunication & ITES
  • Others

Disaster Recovery as a Service (DRaaS), Regional Outlook (Revenue – USD Million, 2016 – 2027)

  • North America
    • U.S.
    • Canada
  • Europe
    • France
    • Germany
    • UK
    • Italy
    • Spain
    • Netherlands
    • Austria
  • Asia Pacific
    • China
    • India
    • Japan
    • Malaysia
    • South Korea
    • Indonesia
  • Central & South America
    • Mexico
    • Brazil
    • Argentina
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Israel
    • South Africa

Rare Disease Genetic Testing Market In-Depth Qualitative Insights & Future Growth Analysis 2020- 2027

 The global rare disease genetic testing market size is expected to reach USD 1.8 Billion by 2027 according to a new study by Polaris Market ResearchThe report “Rare Disease Genetic Testing Market Share, Size, Trends, Industry Analysis Report, By Disease Type (Neurological Disorders, Immunological Disorders, Hematology Ailments, Endocrine & Metabolism Disorders, Cancer, Musculoskeletal Disorders, Cardiovascular Disorders, Dermatology Disorders, Others); By Technology; By Specialty; By End-Use; By Regions; Segment Forecast, 2020 – 2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.

 

The growing need for on-time diagnosis of uncommon disorders, rising prevalence of rare disorders, innovations in genomic testing, and the focused approach of the market player’s in cost-effective treatments are the key factors responsible for market growth. Moreover, government-sponsored schemes are also expected to positively impact the market. In February 2020, the government of India announced financial assistance of INR 15 lacs to the patients suffering from uncommon ailments under the Rashtriya Arogaya Nidhi scheme for a one-time treatment.

 

The global rare disease genetic testing industry is fragmented based on disease type, technology, specialty, end-use, and region. In terms of disease type, the market is segmented into neurological disorders, immunological disorders, hematology illnesses, endocrine & metabolism ailments, cancer, musculoskeletal disorders, cardiovascular disorders, dermatology illnesses, and others.

 

Download Sample Copy : https://www.polarismarketresearch.com/industry-analysis/rare-disease-genetic-testing-market/request-for-sample

 

Based on technology, the rare disease genetic testing industry is further bifurcated into next-generation sequencing, array technology, PCR-based testing, FISH, sanger sequencing, and karyotyping. Based on specialty, the rare disease genetic testing industry is further bifurcated into molecular, chromosomal, and biochemical genomic tests. Based on end-use, the rare disease genomic testing industry is further bifurcated into research laboratories & CROs, hospitals & clinics, and diagnostic laboratories.

  

Segment Highlights

  • Neurological ailments accounted for the largest revenue share in 2019 on account of the increasing prevalence of neurologic disorders across the globe and presence of numerous testing techniques
  • Based on technology, the next generation sequencing segment is projected to constitute almost half of the market in 2027. The usage of the technology in whole genome sequencing is the key factor responsible for its segment’s growth.
  • Molecular tests are expected to account for the highest revenue share by the end of 2027. The availability of advanced technologies and ability to test ultra-rare disorders is expected to drive market growth.
  • Research laboratories & CROs accounted for the largest revenue share in 2019 owing to the increasing number of tests and growing occurrence of rare disorders across the developed economies

 

List of Key Players

  • Strand Life Sciences
  • Myriad Genetics
  • Quest Diagnostics Inc.
  • Centogene N.V.
  • Invitae Corporation
  • Baylor Genetics
  • Ambry Genetics
  • Macrogen, Inc.
  • Opko Health, Inc.
  • Color Genomics, Inc.
  • Health Network Laboratories
  • Preventiongenetics, Progenity, Inc.
  • Fulgent Genetics Inc.
  • Others

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert @ https://www.polarismarketresearch.com/industry-analysis/rare-disease-genetic-testing-market/speak-to-analyst

 

Polaris Market Research has segmented the rare disease genetic testing market report on the basis of disease type, technology, specialty, end-use, and region

Rare Disease Genetic Testing, Disease Type Outlook (Revenue – USD Million, 2016 – 2027)

  • Neurological Disorders
  • Immunological Disorders
  • Hematology Ailments
  • Endocrine & Metabolism Disorders
  • Cancer
  • Musculoskeletal Disorders
  • Cardiovascular Disorders
  • Dermatology Disorders
  • Others

Rare Disease Genetic Testing, Technology Outlook (Revenue – USD Million, 2016 – 2027)

  • Next Generation Sequencing
  • Whole Exome Sequencing
  • Whole Genome Sequencing
  • Array Technology
  • PCR-based Testing
  • FISH
  • Sanger Sequencing
  • Karyotyping

Rare Disease Genetic Testing, Specialty Outlook (Revenue – USD Million, 2016 – 2027)

  • Molecular Genetic Tests
  • Chromosomal Genetic Tests
  • Biochemical Genetic Tests

Rare Disease Genetic Testing, Technology Outlook (Revenue – USD Million, 2016 – 2027)

  • Research Laboratories & CROs
  • Hospitals & Clinics
  • Diagnostic Laboratories

Rare Disease Genetic Testing, Regional Outlook (Revenue – USD Million, 2016 – 2027)

  • North America
    1. U.S.
    2. Canada
  • Europe
    1. France
    2. Germany
    3. UK
    4. Italy
    5. Spain
    6. Netherlands
    7. Austria
  • Asia Pacific
    1. China
    2. India
    3. Japan
    4. Malaysia
    5. South Korea
    6. Indonesia
  • Central & South America
    1. Mexico
    2. Brazil
    3. Argentina
  • Middle East & Africa
    1. UAE
    2. Saudi Arabia
    3. Israel
      • South Africa

Direct Purchase this Market Research Report Now @ https://www.polarismarketresearch.com/checkouts/7391

Cannabis Testing Service Market Future Demands, Latest Innovation By Regional Forecast 2027

 The global cannabis testing service market expected to reach US$ 3.4 billion by 2027 according to a new study by Polaris Market Research. The report “Cannabis Testing Service Market Share, Size, Trends, Industry Analysis Report, By Service (Potency Testing, Terpene Profiling, Heavy Metal Testing, Pesticide Screening, Microscopy Testing, Residual Solvent Screening, and Others); By End-Use; By Regions; Segment Forecast, 2020 – 2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.

 

With the growing need to contain drug abuse and adulteration in cannabis, there is a strong need for quality testing labs in developed economies, this acts as a pivotal factor in boosting the sale of cannabis. Moreover, the positive scenario of scientific literature, clinical trials, and consumer awareness is creating a strong favorable narrative for the market.

 

The global cannabis testing service industry is fragmented based on service, end-use, and region. In terms of service, the market is segmented into potency test, terpene profiling, heavy metal test, pesticide screening, microscopy test, residual solvent screening, and others. Based on end-use, the market is further bifurcated into drug manufacturers, cultivators/growers, and research institutes & labs.

 

Download Sample Copy: https://www.polarismarketresearch.com/industry-analysis/cannabis-testing-service-market/request-for-sample

 

 

Segment Highlights

  • The potency test segment is estimated to hold a major share in the global cannabis testing service industry, as the use of cannabis is rising in medicinal purposes. The segment is expected to witness significant growth over the forecast period.
  • Based on end-use, the cannabis cultivators/growers’ segment is projected to constitute almost half of the market in 2027. The high share is attributed to the fact that most of the cultivator desire to have in-house testing capabilities.
  • North America market accounted for the dominant share in 2019 in terms of revenue owing to the growing research & development in the field of hemp for medical use. In addition, the growing demand for marijuana in healthcare industry is likely to complement market growth

 

List of Key Players

  • Shimadzu Corporation
  • Agilent Technologies
  • PerkinElmer, Inc.
  • Waters Corporation
  • CannaSys, Inc.
  • PharmLabs, LLC
  • Saskatchewan Research Council (SRC)
  • Eurofins Scientific
  • CW ANALYTICAL
  • GreenLeaf Lab
  • Praxis Laboratory
  • SGS Canada Inc.

 

For Further Insights and Segment-Specific Information, Contact a Market Analyst at : https://www.polarismarketresearch.com/industry-analysis/cannabis-testing-service-market/request-for-customization

 

Polaris Market Research has segmented the cannabis testing service market report on the basis service type, end-use, and region

 

Cannabis Testing Service, Service Outlook (Revenue – USD Million, 2016 – 2027)

  • Potency Test
  • Terpene Profiling
  • Heavy Metal Test
  • Pesticide Screening
  • Microscopy Test
  • Residual Solvent Screening
  • Others

Cannabis Testing Service, End-Use Outlook (Revenue – USD Million, 2016 – 2027)

  • Cannabis Drug Manufacturers
  • Cannabis Cultivators/Growers
  • Others (Research Institutes & Labs)

Cannabis Testing Service, Regional Outlook (Revenue – USD Million, 2016 – 2027)

  • North America (U.S., Canada)
  • Europe (France, Germany, UK, Spain, Netherlands, Austria)
  • Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
  • Latin America (Brazil, Mexico, Argentina)
  • MEA (Saudi Arabia, UAE, Israel, South Africa)

Read More : https://www.medgadget.com/2021/02/cannabis-testing-service-market-size-worth-us-3-4-billion-by-2027-cagr-14-9-polaris-market-research.html

C-Reactive Protein Testing Market Covering Prime Factors And Competitive Outlook Till 2027

 The global C-reactive protein testing market expected to Reach US$ 1.99 Billion by 2027 according to a new study by Polaris Market Research. The report “C-Reactive Protein Testing Market Share, Size, Trends, Industry Analysis Report, By Assay Type (Immuno-turbidimetric Assay, ELISA, Chemiluminescence Immunoassay), By Detection Range (hs-CRP, Conventional CRP, cCRP), By Disease Area (Cardiovascular Diseases, Cancer, Rheumatoid Arthritis, Inflammatory Bowel Disease, Endometriosis, Lupus), By End-Use; By Regions; Segment Forecast, 2020 – 2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.

 

The key factors responsible for the market growth are recent surge in COVID-19 cases across the globe, market players’ focused approach towards PoC diagnosis, new innovations, and clinical trials in the biomarker discovery. Moreover, the emerging countries, owing to their huge population base, particularly India and China, focusing on rapid tests, which is cost effective and reliable.

 

The market is fragmented based on assay type, detection range, disease area, end-use, and region. In terms of product, the market is segmented into immuno-turbidimetric assay, ELISA, chemiluminescence immunoassay, and others. Based on detection range, the market is further bifurcated into hs-CRP, conventional CRP, and cCRP. Based on disease area, the market is classified as cardiovascular diseases, cancer, rheumatoid arthritis, inflammatory bowel disease, endometriosis, lupus, and others. The end-use segment is further divided into clinics, hospitals, laboratories, assisted living healthcare facilities, home, and others

 

Download Sample Copy @ https://www.polarismarketresearch.com/industry-analysis/c-reactive-protein-testing-market/request-for-sample

  

Segment Highlights

  • The immuno-turbidimetric segment accounted for the largest revenue share of the market owing to its high specificity and accuracy rate. However, the chemiluminescence assay segment is expected to witness fastest growth over the forecast.
  • Based on detection range, the hs-CRP test segment is projected to constitute almost half of the market in 2027. The segment holds majority of share due to its aggressive use in the healthcare industry to check pandemic infections across the regions.
  • Cardiovascular diseases accounted for the largest revenue share in 2019 on account of the increasing use of C-reactive protein testing CVD across the regions. In addition, the growing incidences of fatal diseases is expected to drive the market growth.
  • North America is accounted for the largest revenue share in 2019 owing to excellent reimbursement setup. However, Asia Pacific is expected to witness fastest revenue growth over the coming years.

 

List of Key Players

  • Merck KGaA
  • Thermo Fisher Scientific, Inc.
  • Roche Ltd.
  • Quest Diagnostics Incorporated
  • Laboratory Corporation of America Holdings
  • Abbott Laboratories
  • Others

 

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert @

https://www.polarismarketresearch.com/industry-analysis/c-reactive-protein-testing-market/speak-to-analyst

 

Polaris Market Research has segmented the C-Reactive Protein Testing Market  report on the basis of Assay Type, Detection Range, Disease Area, Type and Region

 

C-reactive Protein Testing, Assay Type Outlook (Revenue – USD Million, 2016 – 2027)

  • Immuno-turbidimetric Assay
  • ELISA
  • Clinical
  • Nonclinical
  • Chemiluminescence Immunoassay
  • Others

C-reactive Protein Testing, Detection Range Outlook (Revenue – USD Million, 2016 – 2027)

  • hs-CRP
  • Conventional CRP
  • cCRP

C-reactive Protein Testing, Disease Area Outlook (Revenue – USD Million, 2016 – 2027)

  • Cardiovascular Diseases
  • Cancer
  • Rheumatoid Arthritis
  • Inflammatory Bowel Disease
  • Endometriosis
  • Lupus
  • Others

C-reactive Protein Testing, End-Use Outlook (Revenue – USD Million, 2016 – 2027)

  • Clinics
  • Hospitals
  • Laboratories
  • Assisted Living Healthcare Facilities
  • Home
  • Others

C-reactive Protein Testing, Regional Outlook (Revenue – USD Million, 2016 – 2027)

  • North America
    • U.S.
    • Canada
  • Europe
    • France
    • Germany
    • UK
    • Italy
    • Spain
    • Netherlands
    • Austria
  • Asia Pacific
    • China
    • India
    • Japan
    • Malaysia
    • South Korea
    • Indonesia
  • Central & South America
    • Mexico
    • Brazil
    • Argentina
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Israel
    • South Africa

Read More : https://www.medgadget.com/2021/02/c-reactive-protein-testing-market-size-worth-1-99-billion-by-2027-exclusive-study-by-polaris-market-research.html